Podiatrists in Pembroke Pines, FL Accepting Medicare

46 Podiatrists found. Showing 41 - 46

Podiatry Associates Inc. Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 601 N Flamingo Rd Ste 103, Pembroke Pines, FL 33028 Phone: 954-435-2700    Fax: 800-521-3029

Marie Shin, Dpm. Pllc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 2261 N University Dr, Suite200, Pembroke Pines, FL 33024 Phone: 954-987-4991    Fax: 954-987-4922

Christina Michelle Pena Garcia Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 703 N Flamingo Rd, Pembroke Pines, FL 33028 Phone: 954-436-5000

Neal M Bullock, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 17013 Pines Blvd, Pembroke Pines, FL 33027 Phone: 954-450-4200    Fax: 954-450-4237

Dr. Daniel Bell, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 N Flamingo Rd Ste 208, Pembroke Pines, FL 33028 Phone: 954-942-5005    Fax: 954-432-9446

Dr. Susan Elizabeth Gallegos, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 9692 Pines Blvd, Pembroke Pines, FL 33024 Phone: 954-998-4466    Fax: 305-771-0220

News Archive

Neuros Medical announces $1.8 million series A round of investment

Neuros Medical, Inc., a medical device company developing innovative neurostimulation technology for the treatment of chronic pain, announced today a $1.8 million series A round of investment, led by the North Coast Angel Fund (NCAF), which was joined in the investment by Glengary LLC, Ohio Tech Angel Fund, Queen City Angels First Fund III, and individual investors. This round follows the initial investment made earlier in the year from JumpStart Ventures and Case Technology Ventures.

Semel Institute for Neuroscience and Human Behavior awarded $14.9M to establish IPCN facility

The Semel Institute for Neuroscience and Human Behavior at UCLA has been awarded $14.9 million in American Recovery and Reinvestment Act funds to establish a center dedicated to interdisciplinary research on the role of genetic and environmental factors in neuropsychiatric and behavioral disorders.

OncoSec reports positive interim data from ElectroChemotherapy Phase IV head and neck cancer study

OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe.

Ivoclar Vivadent announces acquisition of Wieland Dental

Ivoclar Vivadent, headquartered in Schaan, Liechtenstein, announced the acquisition of Wieland Dental today. The acquisition is planned to be completed in the fourth quarter of 2012. The transaction is still subject to approval by the German Federal Cartel Office.

Winter is not the time to become complacent about COVID-19

We are delighted to see the reduction in the number of cases of SARS-CoV-2 infection occurring in the United Kingdom in recent weeks, with currently 1 in 1900 people in the UK having coronavirus infection.

Read more Medical News

› Verified 7 days ago

• 1
• 2
• 3(current)